Blog
RSS FeedPosted by Michael Wonder on 16 Jul 2019
Why isn’t insulin a complex generic? PA representative asks the FDA
16 July 2019 - Republican Mike Kelly (R-PA) sent a letter Tuesday to US FDA Acting Commissioner Ned Sharpless questioning ...
Posted by Michael Wonder on 15 Jul 2019
China to soften generic drug buying program
15 July 2019 - Chinese drug makers jumped on Monday after a local news report that a centralised drug procurement ...
Posted by Michael Wonder on 10 Jul 2019
FDA announces new efforts to expedite generic drug development and marketing to improve patient access to medicines
10 July 2019 - Today, the U.S. FDA announced a draft guidance, Harmonizing Compendial Standards With Drug Application Approval Using the ...
Posted by Michael Wonder on 27 Jun 2019
Sneaky deals are keeping cheaper generic medicines off the market
27 June 2019 - It’s bad enough drug companies charge sky-high prices for brand-name prescription meds and raise those prices ...
Posted by Michael Wonder on 23 Jun 2019
Epilepsy medicine worry
24 June 2019 - A controversial change of epilepsy drug funding could see her and thousands of other people with ...
Posted by Michael Wonder on 19 Jun 2019
Atomoxetine – delay in change of funded brand and open access
19 June 2019 - PHARMAC is advising all interested parties that there will be a delay in the listing of ...
Posted by Michael Wonder on 18 Jun 2019
FDA releases new data to help generic drug competitors
18 June 2019 - Generic drug applicants will now have more information from the US FDA when deciding whether to ...
Posted by Michael Wonder on 18 Jun 2019
Statement on a new effort to improve transparency and predictability for generic drug applicants to help increase timely access to high-quality, lower cost generic drugs
18 June 2019 - The U.S. FDA is committed to helping facilitate American patients’ access to lower-cost generic medicines by ...
Posted by Michael Wonder on 17 Jun 2019
As global markets for generic drugs fail, poor people pay the price
17 June 2019 - Healthy competition from generic drugs is often held up as a “cure” for high drug prices ...
Posted by Michael Wonder on 13 Jun 2019
Realigning incentives to optimise generic and biosimilar prescribing
13 June 2019 - Drug prices and their impact on total US health care expenditures are again front of mind ...
Posted by Michael Wonder on 29 May 2019
Prices of Canadian generic medicines below international average
29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...
Posted by Michael Wonder on 28 May 2019
Feilding woman nervous about PHARMAC's decision to change epilepsy medication brands
28 My 2019 - Judy Lawrence recalls vividly the day she suffered a seizure walking down the stairs eight years ...
Posted by Michael Wonder on 20 May 2019
FDA's strengthened global inspection program helps ensure generic drug safety
17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines. ...
Posted by Michael Wonder on 13 May 2019
Safety, efficacy, and quality remain top priorities as we continue our work to expand access to cost-saving generic drugs for the American public
13 May 2019 - Millions of Americans have difficulty paying for their prescription medications. ...
Posted by Michael Wonder on 13 May 2019
Intellipharmaceutics announces FDA approval for generic Pristiq
10 May 2019 - Intellipharmaceutics announced today that it has received approval from the U.S. FDA for the Company's abbreviated new ...